Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Enzeevu™ (aflibercept-abzv) – New biosimilar approval

August 12, 2024, Sandoz announced the FDA approval of Enzeevu (aflibercept-abzv), biosimilar to Regeneron’s Eylea® (aflibercept).

Download PDF

Rx navigation